Aptose Reports Results for the Fourth Quarter and Full Year 2019

Mar 10, 2020 4:02pm EDT

Aptose to Release Fourth Quarter and Year End December 31, 2019 Financial Results and Hold Conference Call on March 10, 2020

Feb 25, 2020 7:31am EST

Aptose Biosciences to Host Key Opinion Leader Event Present at BIO CEO & Investor Conference

Jan 29, 2020 7:30am EST

Aptose Biosciences to Present at Biotech Showcase™ 2020 Conference

Jan 07, 2020 7:30am EST

Aptose Announces Closing of Public Offering of Common Shares

Dec 19, 2019 4:02pm EST

Aptose Announces Pricing of Public Offering of Common Shares

Dec 17, 2019 8:00am EST

Aptose Announces Proposed Public Offering of Common Shares

Dec 16, 2019 4:19pm EST

Aptose Presents New Preclinical CG-806 Data at the 2019 ASH Annual Meeting

Dec 09, 2019 11:00am EST

Aptose Presents Highlights From Corporate Event At ASH

Dec 07, 2019 11:00am EST

Aptose Appoints Rafael Bejar, M.D., Ph.D., as Chief Medical Officer

Dec 04, 2019 7:30am EST